Found 5 matching trials
Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778
PHASE1Open-label, single-dose, Phase 1 study to assess the absorption, metabolism...
Location
Multiple Locations
Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO
PHASE2Phase 2a open-label study to assess the efficacy and safety of subcutaneous...
Location
Wilmer Eye Institute
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema
PHASE1The purpose of this study is to evaluate the safety, pharmacokinetics, phar...
Location
Multiple Locations
The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)
PHASE2The purpose of this study is to evaluate the safety and efficacy of subcuta...
Location
Arizona Retina and Vitreous Consultants
The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema
PHASE2The purpose of this study is to evaluate the safety and efficacy of AKB-977...
Location
Multiple Locations